King sues ZymoGenetics in US for false advertising and seeks relief
This article was originally published in Scrip
Executive Summary
A federal judge in Tennessee has lifted three temporary restraining orders (TROs) that barred ZymoGenetics from making certain claims in the marketing of its haemostatic agent, Recothrom (topical recombinant thrombin). But a court battle continues, with further arguments expected to be heard shortly.